发明公开
- 专利标题： NOVEL TYROSINE KINASE INHIBITORS
- 专利标题（中）： 新的酪氨酸激酶抑制剂
-
申请号： EP02723631.4申请日： 2002-03-26
-
公开(公告)号： EP1381598A1公开(公告)日： 2004-01-21
- 发明人: WITTMAN, Mark, D. , BALASUBRAMANIAN, Neelakantan , VELAPARTHI, Upender , ZIMMERMANN, Kurt , SAULNIER, Mark, G. , LIU, Peiying , SANG, Xiaopeng , FRENNESSON, David, B. , STOFFAN, Karen, M. , TARRANT, James, G.
- 申请人： Bristol-Myers Squibb Company
- 申请人地址： P.O. Box 4000,Route 206 and Provinceline Road Princeton, NJ 08543-4000 US
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： P.O. Box 4000,Route 206 and Provinceline Road Princeton, NJ 08543-4000 US
- 代理机构： VOSSIUS & PARTNER
- 优先权： US279327P 20010328
- 国际公布： WO2002079192 20021010
- 主分类号： C07D401/14
- IPC分类号： C07D401/14 ; A61K31/4184
摘要：
The present invention provides compounds of formula I[ ] and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases which can be treated by inhibiting tyrosine kinase enzymes.
信息查询
